NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|6679653|ref|NP_031960|]
View 

glutamyl aminopeptidase [Mus musculus]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
92-531 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 621.52  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   92 VHYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKITKLpELRRPSGEQVPIRRCFEYKKQEYVVIQAAEDLAA 171
Cdd:cd09601   1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSA-SLTLKGGSGIIEVTVVTDEETEFLTITLDETLPP 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  172 tsgDSVYRLTMEFKGWLNGSLVGFYKTTYM-EDGQIRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSN 250
Cdd:cd09601  80 ---GENYTLSIEFTGKLNDDLRGFYRSSYTdEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSN 156
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  251 MPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQAVFDYFEDYFA 330
Cdd:cd09601 157 MPPVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFG 236
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  331 MEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSNQQRVASVVAHELVHQWFGNTVTMDWWDDLWLNEGF 410
Cdd:cd09601 237 IPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGF 316
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  411 ASFFEFLGVNHAEKDWQMLSQVLLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASILRMLQDWITPEKF 490
Cdd:cd09601 317 ATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVF 396
                       410       420       430       440
                ....*....|....*....|....*....|....*....|....*
gi 6679653  491 QKGCQIYLKKFQFANAKTSDFWDSLQEAS----NLPVKEVMDTWT 531
Cdd:cd09601 397 RKGLRKYLKKHAYGNATTDDLWEALQEASgeskPLDVKEIMDSWT 441
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
607-925 7.35e-96

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 304.58  E-value: 7.35e-96
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    607 FLKINPDHIGFYRVNYEGGTWDWIAEALssNHTRFSAADRSSFIDDAFALARAQLLNYKIALNLTMYLKSEEDFLPWERV 686
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    687 ISSVSYIISMFEDDrELYPMIETYFQGQVKPVADLLGWQD--TGSHITKLLRASILGFACKMGDREALGNASQLFDSWLK 764
Cdd:pfam11838  79 LSQLSTLRSLLSAD-PEYEALKAFLRKLLSPLAEKLGWEAppGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    765 GSASIPVNLRLLVYRYGMQNsGNEAAWNYTLEQYQKTSLAQEKEKLLYGLASVKDVKLLARYLEMLKDPNIIKTQDVFTV 844
Cdd:pfam11838 158 GDDAIPPDLRWAVYCAAVAN-GGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDLRAV 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    845 IRYISYNSYGKTMAWNWIQLNWDYLVSRFTINDrYLGRIVT-IAEPFNTELQLWQMQSFFAKYPNAGAgAKPREQVLETV 923
Cdd:pfam11838 237 IAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKgLTPSFSTEEELDEVEAFFADKDTPGL-RRALAQALETI 314

                  ..
gi 6679653    924 KN 925
Cdd:pfam11838 315 RR 316
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
92-531 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 621.52  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   92 VHYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKITKLpELRRPSGEQVPIRRCFEYKKQEYVVIQAAEDLAA 171
Cdd:cd09601   1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSA-SLTLKGGSGIIEVTVVTDEETEFLTITLDETLPP 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  172 tsgDSVYRLTMEFKGWLNGSLVGFYKTTYM-EDGQIRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSN 250
Cdd:cd09601  80 ---GENYTLSIEFTGKLNDDLRGFYRSSYTdEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSN 156
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  251 MPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQAVFDYFEDYFA 330
Cdd:cd09601 157 MPPVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFG 236
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  331 MEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSNQQRVASVVAHELVHQWFGNTVTMDWWDDLWLNEGF 410
Cdd:cd09601 237 IPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGF 316
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  411 ASFFEFLGVNHAEKDWQMLSQVLLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASILRMLQDWITPEKF 490
Cdd:cd09601 317 ATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVF 396
                       410       420       430       440
                ....*....|....*....|....*....|....*....|....*
gi 6679653  491 QKGCQIYLKKFQFANAKTSDFWDSLQEAS----NLPVKEVMDTWT 531
Cdd:cd09601 397 RKGLRKYLKKHAYGNATTDDLWEALQEASgeskPLDVKEIMDSWT 441
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
84-576 1.20e-126

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 396.32  E-value: 1.20e-126
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   84 RLPDFINPVHYDLEVKALMEEDRYTGIVTISVN-LSKPTRDLWLHIRETKITKLpelrRPSGEQVPirrcFEYKKQEyVV 162
Cdd:COG0308  10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTaTEAPLDSLVLDLKGLEVTSV----TVDGKPLD----FTRDGER-LT 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  163 IQAAEDLAAtsgDSVYRLTMEFKGWLNGSLVGFYKTTYMEDGqiRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHP 242
Cdd:COG0308  81 ITLPKPLAP---GETFTLEIEYSGKPSNGGEGLYRSGDPPDG--PPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVP 155
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  243 KEYSALSNMPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQAVF 322
Cdd:COG0308 156 AGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRML 235
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  323 DYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDplLSASSNQQRVASVVAHELVHQWFGNTVTMDWWD 402
Cdd:COG0308 236 DFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLADE--TATDADYERRESVIAHELAHQWFGNLVTCADWD 313
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  403 DLWLNEGFASFFEFLGVNHA--EKDWQMLSQVLLEDVFPVQedDSLMSSHPVVVTvsTPAEITSVFDGISYSKGASILRM 480
Cdd:COG0308 314 DLWLNEGFATYMEQLFSEDLygKDAADRIFVGALRSYAFAE--DAGPNAHPIRPD--DYPEIENFFDGIVYEKGALVLHM 389
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  481 LQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASNLPVKEVMDTWTSQMGYPVVTVSGRQNITQKRFLldskaDP 560
Cdd:COG0308 390 LRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGKVTL-----TL 464
                       490
                ....*....|....*.
gi 6679653  561 SQPPSElGYTWNIPVR 576
Cdd:COG0308 465 RQTPPR-PHPFHIPLE 479
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
313-530 2.59e-115

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 351.98  E-value: 2.59e-115
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    313 YAANITQAVFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSNQQRVASVVAHELVHQWF 392
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    393 GNTVTMDWWDDLWLNEGFASFFEFLGVNHAEKDWQMLSQVLLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYS 472
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 6679653    473 KGASILRMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASN-LPVKEVMDTW 530
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
607-925 7.35e-96

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 304.58  E-value: 7.35e-96
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    607 FLKINPDHIGFYRVNYEGGTWDWIAEALssNHTRFSAADRSSFIDDAFALARAQLLNYKIALNLTMYLKSEEDFLPWERV 686
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    687 ISSVSYIISMFEDDrELYPMIETYFQGQVKPVADLLGWQD--TGSHITKLLRASILGFACKMGDREALGNASQLFDSWLK 764
Cdd:pfam11838  79 LSQLSTLRSLLSAD-PEYEALKAFLRKLLSPLAEKLGWEAppGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    765 GSASIPVNLRLLVYRYGMQNsGNEAAWNYTLEQYQKTSLAQEKEKLLYGLASVKDVKLLARYLEMLKDPNIIKTQDVFTV 844
Cdd:pfam11838 158 GDDAIPPDLRWAVYCAAVAN-GGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDLRAV 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    845 IRYISYNSYGKTMAWNWIQLNWDYLVSRFTINDrYLGRIVT-IAEPFNTELQLWQMQSFFAKYPNAGAgAKPREQVLETV 923
Cdd:pfam11838 237 IAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKgLTPSFSTEEELDEVEAFFADKDTPGL-RRALAQALETI 314

                  ..
gi 6679653    924 KN 925
Cdd:pfam11838 315 RR 316
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
212-635 1.52e-72

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 256.25  E-value: 1.52e-72
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    212 TDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSNMPEE--KSEMVDDNWKkttFVKSVPMSTYLVCFAVHRFTAI 289
Cdd:TIGR02412 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETdvTPEPADRRWE---FPETPKLSTYLTAVAAGPYHSV 198
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    290 ERKSRSgKPLKVYVQP--NQKETAEYAANITQAVFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYREtNLLYD 367
Cdd:TIGR02412 199 QDESRS-YPLGIYARRslAQYLDADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAE-NFLHR 276
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    368 PLLSASSNQQRvASVVAHELVHQWFGNTVTMDWWDDLWLNEGFASFFEflgvNHAEKD-------WQmlsqvlledVFPV 440
Cdd:TIGR02412 277 AEATRAEKENR-AGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMG----TLASAEateytdaWT---------TFAA 342
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    441 Q------EDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASILRMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDS 514
Cdd:TIGR02412 343 QgkqwayEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDS 422
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    515 LQEASNLPVKEVMDTWTSQMGYPVVTVsgrqNITQKRFLLDS-KADPSQPPSElgYTWNIPVRWADNDNSRITVYNRLD- 592
Cdd:TIGR02412 423 LAKASGRDLSAWSDAWLETAGVNTLTP----EITTDGGVVSAlYPESSGPPRP--HRIAIGLYDLDRDDLRRTTLVPLTi 496
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*.
gi 6679653    593 KGGITLNANLSGD---AFLKINPDHIGFYRVNYEGGTWDWIAEALS 635
Cdd:TIGR02412 497 SGERTAVPQLVGKrapALVLLNDDDLTYAKVRLDPTSFDTVLAALS 542
pepN PRK14015
aminopeptidase N; Provisional
285-563 5.45e-18

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 89.42  E-value: 5.45e-18
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   285 RFTaierkSRSGK--PLKVYVQPNQKETAEYAaniTQAV-----FDyfEDYFAMEYALPKLDKIAIPDFGTGAMENWGLv 357
Cdd:PRK14015 205 TFT-----TRSGRevALEIYVEPGNLDKCDHA---MDSLkksmkWD--EERFGLEYDLDIFMIVAVDDFNMGAMENKGL- 273
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   358 tyretNLLYDPLLSASS------NQQRVASVVAHELVHQWFGNTVTM-DWWDdLWLNEGFASFfeflgvnhaeKDwQMLS 430
Cdd:PRK14015 274 -----NIFNSKYVLADPetatdaDYERIESVIAHEYFHNWTGNRVTCrDWFQ-LSLKEGLTVF----------RD-QEFS 336
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   431 QVL-------LEDV-------FPvqEDDSLMSsHPVV------------VTVstpaeitsvfdgisYSKGASILRMLQDW 484
Cdd:PRK14015 337 ADLgsravkrIEDVrvlraaqFA--EDAGPMA-HPVRpdsyieinnfytATV--------------YEKGAEVIRMLHTL 399
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   485 ITPEKFQKGCQIYLKKF--QfAnAKTSDFWDSLQEASNLPVKEVMdTWTSQMGYPVVTVSGRQNITQKRFLLD----SKA 558
Cdd:PRK14015 400 LGEEGFRKGMDLYFERHdgQ-A-VTCEDFVAAMEDASGRDLSQFR-RWYSQAGTPRVTVSDEYDAAAGTYTLTlsqsTPP 476

                 ....*
gi 6679653   559 DPSQP 563
Cdd:PRK14015 477 TPGQP 481
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
92-531 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 621.52  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   92 VHYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKITKLpELRRPSGEQVPIRRCFEYKKQEYVVIQAAEDLAA 171
Cdd:cd09601   1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSA-SLTLKGGSGIIEVTVVTDEETEFLTITLDETLPP 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  172 tsgDSVYRLTMEFKGWLNGSLVGFYKTTYM-EDGQIRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSN 250
Cdd:cd09601  80 ---GENYTLSIEFTGKLNDDLRGFYRSSYTdEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSN 156
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  251 MPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQAVFDYFEDYFA 330
Cdd:cd09601 157 MPPVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFG 236
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  331 MEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSNQQRVASVVAHELVHQWFGNTVTMDWWDDLWLNEGF 410
Cdd:cd09601 237 IPYPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGF 316
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  411 ASFFEFLGVNHAEKDWQMLSQVLLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASILRMLQDWITPEKF 490
Cdd:cd09601 317 ATYMEYLAVDKLFPEWNMWDQFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVF 396
                       410       420       430       440
                ....*....|....*....|....*....|....*....|....*
gi 6679653  491 QKGCQIYLKKFQFANAKTSDFWDSLQEAS----NLPVKEVMDTWT 531
Cdd:cd09601 397 RKGLRKYLKKHAYGNATTDDLWEALQEASgeskPLDVKEIMDSWT 441
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
84-576 1.20e-126

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 396.32  E-value: 1.20e-126
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   84 RLPDFINPVHYDLEVKALMEEDRYTGIVTISVN-LSKPTRDLWLHIRETKITKLpelrRPSGEQVPirrcFEYKKQEyVV 162
Cdd:COG0308  10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTaTEAPLDSLVLDLKGLEVTSV----TVDGKPLD----FTRDGER-LT 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  163 IQAAEDLAAtsgDSVYRLTMEFKGWLNGSLVGFYKTTYMEDGqiRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHP 242
Cdd:COG0308  81 ITLPKPLAP---GETFTLEIEYSGKPSNGGEGLYRSGDPPDG--PPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVP 155
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  243 KEYSALSNMPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQAVF 322
Cdd:COG0308 156 AGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRML 235
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  323 DYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDplLSASSNQQRVASVVAHELVHQWFGNTVTMDWWD 402
Cdd:COG0308 236 DFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLADE--TATDADYERRESVIAHELAHQWFGNLVTCADWD 313
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  403 DLWLNEGFASFFEFLGVNHA--EKDWQMLSQVLLEDVFPVQedDSLMSSHPVVVTvsTPAEITSVFDGISYSKGASILRM 480
Cdd:COG0308 314 DLWLNEGFATYMEQLFSEDLygKDAADRIFVGALRSYAFAE--DAGPNAHPIRPD--DYPEIENFFDGIVYEKGALVLHM 389
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  481 LQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASNLPVKEVMDTWTSQMGYPVVTVSGRQNITQKRFLldskaDP 560
Cdd:COG0308 390 LRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGKVTL-----TL 464
                       490
                ....*....|....*.
gi 6679653  561 SQPPSElGYTWNIPVR 576
Cdd:COG0308 465 RQTPPR-PHPFHIPLE 479
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
313-530 2.59e-115

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 351.98  E-value: 2.59e-115
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    313 YAANITQAVFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSNQQRVASVVAHELVHQWF 392
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    393 GNTVTMDWWDDLWLNEGFASFFEFLGVNHAEKDWQMLSQVLLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYS 472
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*....
gi 6679653    473 KGASILRMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASN-LPVKEVMDTW 530
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEASGpLDVDSFMDTW 219
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
89-530 2.72e-100

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 321.00  E-value: 2.72e-100
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   89 INPVHYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKITKLpELrrpSGEQVPirrcFEYKKQEYVVIQAAED 168
Cdd:cd09602  13 ISVVSYDLDLDLTEGAETFRGTVTIRFTLREPGASLFLDFRGGEVKSV-TL---NGRPLD----PSAFDGERITLPGLLK 84
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  169 LAATsgdsvyRLTMEFKGwLNGSL-VGFYKTTYMEDGQIRSIaaTDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSA 247
Cdd:cd09602  85 AGEN------TVVVEFTA-PYSSDgEGLHRFVDPADGETYLY--TLFEPDDARRVFPCFDQPDLKATFTLTVTAPADWTV 155
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  248 LSNMPEEKSEMVDDNwKKTTFVKSVPMSTYLVCFAVHRFTAIERkSRSGKPLKVYVqpnqKET-AEYAAN------ITQA 320
Cdd:cd09602 156 ISNGPETSTEEAGGR-KRWRFAETPPLSTYLFAFVAGPYHRVED-EHDGIPLGLYC----RESlAEYERDadeifeVTKQ 229
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  321 VFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPllsASSNQ-QRVASVVAHELVHQWFGNTVTMD 399
Cdd:cd09602 230 GLDFYEDYFGIPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFREE---PTRAQrLRRANTILHEMAHMWFGDLVTMK 306
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  400 WWDDLWLNEGFASFFEFLGVNHA------------EKDWQMLSQvlledvfpvqedDSLMSSHPVVVTVSTPAEITSVFD 467
Cdd:cd09602 307 WWDDLWLNESFADFMAAKALAEAtpftdawltfllRRKPWAYRA------------DQLPTTHPIAQDVPDLEAAGSNFD 374
                       410       420       430       440       450       460
                ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 6679653  468 GISYSKGASILRMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASNLPVKEVMDTW 530
Cdd:cd09602 375 GITYAKGASVLKQLVALVGEEAFRAGLREYFKKHAYGNATLDDLIAALDEASGRDLSAWADAW 437
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
607-925 7.35e-96

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 304.58  E-value: 7.35e-96
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    607 FLKINPDHIGFYRVNYEGGTWDWIAEALssNHTRFSAADRSSFIDDAFALARAQLLNYKIALNLTMYLKSEEDFLPWERV 686
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    687 ISSVSYIISMFEDDrELYPMIETYFQGQVKPVADLLGWQD--TGSHITKLLRASILGFACKMGDREALGNASQLFDSWLK 764
Cdd:pfam11838  79 LSQLSTLRSLLSAD-PEYEALKAFLRKLLSPLAEKLGWEAppGESHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    765 GSASIPVNLRLLVYRYGMQNsGNEAAWNYTLEQYQKTSLAQEKEKLLYGLASVKDVKLLARYLEMLKDPNIIKTQDVFTV 844
Cdd:pfam11838 158 GDDAIPPDLRWAVYCAAVAN-GGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDLRAV 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    845 IRYISYNSYGKTMAWNWIQLNWDYLVSRFTINDrYLGRIVT-IAEPFNTELQLWQMQSFFAKYPNAGAgAKPREQVLETV 923
Cdd:pfam11838 237 IAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKgLTPSFSTEEELDEVEAFFADKDTPGL-RRALAQALETI 314

                  ..
gi 6679653    924 KN 925
Cdd:pfam11838 315 RR 316
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
92-517 7.34e-92

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 297.43  E-value: 7.34e-92
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   92 VHYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKI---------TKLPELRRPSGEQVPIRRCFEyKKQEYVV 162
Cdd:cd09595   1 YHYDLDLDVDFTTKTLNGTETLTVDASQVGRELVLDLVGLTIhsvsvngaaVDFGEREHYDGEKLTIPGPKP-PGQTFTV 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  163 iqaaedlaatsgdsvyrlTMEFKGWLNGSLVGFYKTTYMedGQIRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHP 242
Cdd:cd09595  80 ------------------RISFEAKPSKNLLGWLWEQTA--GKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTP 139
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  243 KEYSALSNMPEEKSEMVDDNWKKTTFVKSVPMSTYLVCFAVH--RFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQA 320
Cdd:cd09595 140 KKDLLASNGALVGEETGANGRKTYRFEDTPPIPTYLVAVVVGdlEFKYVTVKSQPRVGLSVYSEPLQVDQAQYAFDATRA 219
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  321 VFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSnqQRVASVVAHELVHQWFGNTVTMDW 400
Cdd:cd09595 220 ALAWFEDYFGGPYPLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRSKVTDTGA--RSIENVIAHELAHQWFGNLVTMRW 297
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  401 WDDLWLNEGFASFFE--FLGVNHAEKDWQMLSqvlLEDVFPVQEDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASIL 478
Cdd:cd09595 298 WNDLWLNEGFAVYYEnrIMDATFGTSSRHLDQ---LSGSSDLNTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGALVL 374
                       410       420       430
                ....*....|....*....|....*....|....*....
gi 6679653  479 RMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQE 517
Cdd:cd09595 375 RMLEELVGEEAFDKGVQAYFNRHKFKNATTDDFIDALEE 413
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
91-278 1.06e-74

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 243.02  E-value: 1.06e-74
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653     91 PVHYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKITKLPELRRPSGEQVPIRRCFEYKKQEYVVIQAAEDLA 170
Cdd:pfam17900   2 PEHYDLDLKIDLKNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLSDEVTSDGVPADFTEDQKDGEKLTIVLPETLN 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    171 ATSgdsVYRLTMEFKGWLNGSLVGFYKTTYMEDGQIRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSN 250
Cdd:pfam17900  82 QTG---PYTLEIEYSGELNDSMTGFYRSTYTDNGEKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTALSN 158
                         170       180
                  ....*....|....*....|....*...
gi 6679653    251 MPEEKSEMVDDNWKKTTFVKSVPMSTYL 278
Cdd:pfam17900 159 MPVIASEPLENGWVITTFEQTPKMSTYL 186
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
212-635 1.52e-72

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 256.25  E-value: 1.52e-72
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    212 TDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSNMPEE--KSEMVDDNWKkttFVKSVPMSTYLVCFAVHRFTAI 289
Cdd:TIGR02412 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISNSRETdvTPEPADRRWE---FPETPKLSTYLTAVAAGPYHSV 198
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    290 ERKSRSgKPLKVYVQP--NQKETAEYAANITQAVFDYFEDYFAMEYALPKLDKIAIPDFGTGAMENWGLVTYREtNLLYD 367
Cdd:TIGR02412 199 QDESRS-YPLGIYARRslAQYLDADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAE-NFLHR 276
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    368 PLLSASSNQQRvASVVAHELVHQWFGNTVTMDWWDDLWLNEGFASFFEflgvNHAEKD-------WQmlsqvlledVFPV 440
Cdd:TIGR02412 277 AEATRAEKENR-AGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMG----TLASAEateytdaWT---------TFAA 342
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    441 Q------EDDSLMSSHPVVVTVSTPAEITSVFDGISYSKGASILRMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDS 514
Cdd:TIGR02412 343 QgkqwayEADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDS 422
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    515 LQEASNLPVKEVMDTWTSQMGYPVVTVsgrqNITQKRFLLDS-KADPSQPPSElgYTWNIPVRWADNDNSRITVYNRLD- 592
Cdd:TIGR02412 423 LAKASGRDLSAWSDAWLETAGVNTLTP----EITTDGGVVSAlYPESSGPPRP--HRIAIGLYDLDRDDLRRTTLVPLTi 496
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*.
gi 6679653    593 KGGITLNANLSGD---AFLKINPDHIGFYRVNYEGGTWDWIAEALS 635
Cdd:TIGR02412 497 SGERTAVPQLVGKrapALVLLNDDDLTYAKVRLDPTSFDTVLAALS 542
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
93-530 6.58e-69

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 235.56  E-value: 6.58e-69
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   93 HYDLEVKALMEEDRYTGIVTISVNLSKPTRDLWLHIRETKITKLpELrrpsgEQVPIRRcFEYKKQEyVVIQAAEDLAAt 172
Cdd:cd09603   5 HYDLDLDYDPATKSLSGTATITFRATQDLDSLQLDLVGLTVSSV-TV-----DGVPAAF-FTHDGDK-LVITLPRPLAA- 75
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  173 sgDSVYRLTMEFKGWLNGSLVGFYKTTYMEDGqiRSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHPKEYSALSN-M 251
Cdd:cd09603  76 --GETFTVTVRYSGKPRPAGYPPGDGGGWEEG--DDGVWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVVSNgR 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  252 PEEKSEmVDDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSGKPLKVYVQPNQKETAEYAANITQAVFDYFEDYFAm 331
Cdd:cd09603 152 LVSTTT-NGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGSGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEELFG- 229
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  332 EYALPKLDKIAIPDFGtGAMENWGLVTYRETNLLYDPllsassnqqRVASVVAHELVHQWFGNTVTMDWWDDLWLNEGFA 411
Cdd:cd09603 230 PYPFEKYGQVVVPDLG-GGMEHQTATTYGNNFLNGDR---------GSERLIAHELAHQWFGDSVTCADWADIWLNEGFA 299
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  412 SFFEFLGVNHAEKDWQMLSQVLledvfpvQEDDSLMSSHPVVVTVSTPAEItsvFDGISYSKGASILRMLQDWITPEKFQ 491
Cdd:cd09603 300 TYAEWLWSEHKGGADAYRAYLA-------GQRQDYLNADPGPGRPPDPDDL---FDRDVYQKGALVLHMLRNLLGDEAFF 369
                       410       420       430
                ....*....|....*....|....*....|....*....
gi 6679653  492 KGCQIYLKKFQFANAKTSDFWDSLQEASNLPVKEVMDTW 530
Cdd:cd09603 370 AALRAYLARYAHGNVTTEDFIAAAEEVSGRDLTWFFDQW 408
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
189-521 4.00e-32

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 130.33  E-value: 4.00e-32
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  189 NGSLVGFYKTTymedgqirSIAATDHEPTDARKSFPCFDEPNKKSTYSISIIHPKE-YSA-LSNMPEEKSEMVDDNWKKT 266
Cdd:cd09600  96 NTSLEGLYKSG--------GILCTQCEAEGFRRITYFPDRPDVMSKFTVTIEADKEkYPVlLSNGNLIEEGELPNGRHFA 167
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  267 TFVKSVPMSTYLvcFAV---------HRFTaierkSRSGKP--LKVYVQPNQKETAEYAANITQAVFDYFEDYFAMEYAL 335
Cdd:cd09600 168 VWEDPFPKPSYL--FALvagdlgsveDTFT-----TKSGRKvkLRIYVEPGNEDKCHHAMESLKKAMKWDEERFGLEYDL 240
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  336 PKLDKIAIPDFGTGAMENWGLVTYRETNLLYDPLLSASSNQQRVASVVAHELVHQWFGNTVTMDWWDDLWLNEGFASFF- 414
Cdd:cd09600 241 DLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGLTVFRd 320
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  415 -EFLGvnhaekdwQMLSQVL--LEDV-------FPvqEDDSLMsSHPVvvtvsTPA---EITSVFDGISYSKGASILRML 481
Cdd:cd09600 321 qEFSA--------DMNSRAVkrIEDVrrlrsaqFP--EDAGPM-AHPI-----RPDsyiEINNFYTVTVYEKGAEVIRML 384
                       330       340       350       360
                ....*....|....*....|....*....|....*....|
gi 6679653  482 QDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASNL 521
Cdd:cd09600 385 HTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGR 424
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
215-517 1.68e-30

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 125.65  E-value: 1.68e-30
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  215 EPTDARKSFPCFDEPNKKSTYSISIIHPKEYSAL-SNMPEEKSEmvDDNWKKTTFVKSVPMSTYLVCFAVhrfTAIERKS 293
Cdd:cd09599 132 QAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALmSALRTGEKE--EAGTGTYTFEQPVPIPSYLIAIAV---GDLESRE 206
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  294 ---RSGkplkVYVQPNQKETAEYAANITQAVFDYFEDYFaMEYA--------LPkldkiaiPDFGTGAMENwglvtyret 362
Cdd:cd09599 207 igpRSG----VWAEPSVVDAAAEEFADTEKFLKAAEKLY-GPYVwgrydllvLP-------PSFPYGGMEN--------- 265
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  363 nllydPLLS-AS--------SNqqrvASVVAHELVHQWFGNTVTMDWWDDLWLNEGFASFFE--FLGVNHAEKDWQMLSQ 431
Cdd:cd09599 266 -----PCLTfATptliagdrSL----VDVIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLErrILERLYGEEYRQFEAI 336
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  432 V----LLEDVFPVQEDDSLMSSHPVVVTVStPAEitsVFDGISYSKGASILRMLQDWITPEKFQKGCQIYLKKFQFANAK 507
Cdd:cd09599 337 LgwkdLQESIKEFGEDPPYTLLVPDLKGVD-PDD---AFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSID 412
                       330
                ....*....|
gi 6679653  508 TSDFWDSLQE 517
Cdd:cd09599 413 TEDFKDFLLE 422
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
233-530 8.65e-26

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 111.60  E-value: 8.65e-26
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  233 STYSISIIHPKEYSALSNMPEEKSEMVDDNWKKTTFVKSvpmstylvcfAVHRFT-------AIERKSRSGKPLKVYVQP 305
Cdd:cd09604 161 GDYDVTITVPKNYVVAATGELQNPEEVLDGTKTWHFKAE----------NVRDFAwaaspdfVVDAATVDGVTVNVYYLP 230
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  306 NQKETAEYAANITQAVFDYFEDYFaMEYALPKLDkIAIPDFGTGAMENWGLVTYRETNLLYDPLLsassnqqrvASVVAH 385
Cdd:cd09604 231 ENAEAAERALEYAKDALEFFSEKF-GPYPYPELD-VVQGPFGGGGMEYPGLVFIGSRLYDPKRSL---------EGVVVH 299
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  386 ELVHQWFGNTVTMDWWDDLWLNEGFASFFEFLGVNHAEKDWQMLSQVLLEDVFPVQEDDSLmsshPVVVTVSTPAEITSV 465
Cdd:cd09604 300 EIAHQWFYGIVGNDERREPWLDEGLATYAESLYLEEKYGKEAADELLGRRYYRAYARGPGG----PINLPLDTFPDGSYY 375
                       250       260       270       280       290       300
                ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 6679653  466 FDgISYSKGASILRMLQDWITPEKFQKGCQIYLKKFQFANAKTSDFWDSLQEASNLPVKEVMDTW 530
Cdd:cd09604 376 SN-AVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAEEVSGKDLDWFFRGW 439
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
86-517 2.66e-25

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 111.79  E-value: 2.66e-25
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653     86 PDFINPVHYDLEVKALMEEDRYTGIVTISVN-LSKPTRDLWLHIRETKITKLPELRRPSGEQVPIRRcfEYKKQEYVVIQ 164
Cdd:TIGR02411   8 YKDFRTSHTDLNLSVDFTKRKLSGSVTFTLKsLTDNLNKLVLDTSYLDIQKVTINGLPADFAIGERK--EPLGSPLTISL 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    165 AAEdlaATSGDSvYRLTMEFKG--------WLNGSLVGFYKTTYMEDgQIRSIaatdHeptdARKSFPCFDEPNKKSTYS 236
Cdd:TIGR02411  86 PIA---TSKNDE-FVLNISFSTtpkctalqWLNPEQTSGKKHPYLFS-QCQAI----H----ARSLFPCQDTPSVKSTYT 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    237 ISIIHPkeYSAL-SNMPEEKSEmvdDNWKKTTFVKSVPMSTYLVCFAVHRFTAIERKSRSgkplKVYVQPNQKETAEYAA 315
Cdd:TIGR02411 153 AEVESP--LPVLmSGIRDGETS---NDPGKYLFKQKVPIPAYLIAIASGDLASAPIGPRS----TVYSEPEQLEKCQYEF 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    316 NITQAVFDYFEDYFAMEYALPKLDKIAIPD-FGTGAMENwglvtyreTNLLY-DPLLSASSNQQrvASVVAHELVHQWFG 393
Cdd:TIGR02411 224 ENDTEKFIKTAEDLIFPYEWGQYDLLVLPPsFPYGGMEN--------PNLTFaTPTLIAGDRSN--VDVIAHELAHSWSG 293
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653    394 NTVTMDWWDDLWLNEGFASFFE--FLGVNHAEK--DWQMLS--QVLLEDVFPVQEDDSLMSshpVVVTVsTPAEITSVFD 467
Cdd:TIGR02411 294 NLVTNCSWEHFWLNEGWTVYLErrIIGRLYGEKtrHFSALIgwGDLQESVKTLGETPEFTK---LVVDL-KDNDPDDAFS 369
                         410       420       430       440       450
                  ....*....|....*....|....*....|....*....|....*....|.
gi 6679653    468 GISYSKGASILRMLQDWI-TPEKFQKGCQIYLKKFQFANAKTSDFWDSLQE 517
Cdd:TIGR02411 370 SVPYEKGFNFLFYLEQLLgGPAEFDPFLRHYFKKFAYKSLDTYQFKDALYE 420
pepN PRK14015
aminopeptidase N; Provisional
285-563 5.45e-18

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 89.42  E-value: 5.45e-18
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   285 RFTaierkSRSGK--PLKVYVQPNQKETAEYAaniTQAV-----FDyfEDYFAMEYALPKLDKIAIPDFGTGAMENWGLv 357
Cdd:PRK14015 205 TFT-----TRSGRevALEIYVEPGNLDKCDHA---MDSLkksmkWD--EERFGLEYDLDIFMIVAVDDFNMGAMENKGL- 273
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   358 tyretNLLYDPLLSASS------NQQRVASVVAHELVHQWFGNTVTM-DWWDdLWLNEGFASFfeflgvnhaeKDwQMLS 430
Cdd:PRK14015 274 -----NIFNSKYVLADPetatdaDYERIESVIAHEYFHNWTGNRVTCrDWFQ-LSLKEGLTVF----------RD-QEFS 336
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   431 QVL-------LEDV-------FPvqEDDSLMSsHPVV------------VTVstpaeitsvfdgisYSKGASILRMLQDW 484
Cdd:PRK14015 337 ADLgsravkrIEDVrvlraaqFA--EDAGPMA-HPVRpdsyieinnfytATV--------------YEKGAEVIRMLHTL 399
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653   485 ITPEKFQKGCQIYLKKF--QfAnAKTSDFWDSLQEASNLPVKEVMdTWTSQMGYPVVTVSGRQNITQKRFLLD----SKA 558
Cdd:PRK14015 400 LGEEGFRKGMDLYFERHdgQ-A-VTCEDFVAAMEDASGRDLSQFR-RWYSQAGTPRVTVSDEYDAAAGTYTLTlsqsTPP 476

                 ....*
gi 6679653   559 DPSQP 563
Cdd:PRK14015 477 TPGQP 481
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
317-417 3.91e-11

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 60.58  E-value: 3.91e-11
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  317 ITQAVFDYFEDYF----AMEYALPKLDKIAIPDFGTGAMENwGLVTYrETNLLYDPLLSASSNQQRVasVVAHELVHQWF 392
Cdd:cd09594   3 YAHETYKYYEELLgrtsFRYPVSPIYSLLVYPAYVEVNAYN-AMWIP-STNIFYGAGILDTLSGTID--VLAHELTHAFT 78
                        90       100
                ....*....|....*....|....*.
gi 6679653  393 GNTVTMDW-WDDLWLNEGFASFFEFL 417
Cdd:cd09594  79 GQFSNLMYsWSSGWLNEGISDYFGGL 104
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
223-413 2.53e-10

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 64.17  E-value: 2.53e-10
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  223 FPCFDEPNKKSTYSISIIHPK----------------EYSALSNMPEEKSEMV--------------DDNWKKT-TFVKS 271
Cdd:cd09839 180 FPCVDSLWERCTWELEITVPRtlgdagrpplagskedEDDDDLTEEDKELEMVvvcsgdlveqvvhpEDPSKKTfSFSLS 259
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  272 VPMSTYLVCFAVHRFTAI-----------ERKSRSGKPLKVYVQPNQKETAEYAANITQAVFDYFEDYFAM----EYALP 336
Cdd:cd09839 260 NPTSAQHIGFAVGPFEIVplpefreseedDKLGSSAVEVTGFCLPGRLEELRNTCSFLHKAMDFFEEEYGSypfsSYKQV 339
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 6679653  337 KLDKiAIPDFGTGAmenwGLVTYrETNLLY-----DPLLSassnqqrVASVVAHELVHQWFGNTVTMDWWDDLWLNEGFA 411
Cdd:cd09839 340 FVDD-LPEDVSSFA----SLSIC-SSRLLYppdiiDQAYE-------TRRKLAHALASQWFGINIIPKTWSDTWLVIGIA 406

                ..
gi 6679653  412 SF 413
Cdd:cd09839 407 GY 408
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH